StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Mankind Pharma Limited
NSE:MANKIND.NS
Sector
Location
Market Cap
USD 12.81 B
Share Price
USD 31.12
Avg Daily Volume
441,236
Change (1 day)
-0.75%
Change (1 year)
21.10%
Change (YTD)
-7.51%
Mankind Pharma Limited EBITDA Margin for the year ending March 31, 2025: 24.72%
Mankind Pharma Limited EBITDA Margin is 24.72% for the year ending March 31, 2025, a -9.06% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Mankind Pharma Limited EBITDA Margin for the year ending March 31, 2024 was 27.18%, a 17.27% change year over year.
-
Mankind Pharma Limited EBITDA Margin for the year ending March 31, 2023 was 23.18%, a -15.98% change year over year.
-
Mankind Pharma Limited EBITDA Margin for the year ending March 31, 2022 was 27.59%, a -5.61% change year over year.
-
Mankind Pharma Limited EBITDA Margin for the year ending March 31, 2021 was 29.23%, a 11.27% change year over year.
Competitors
Zydus Lifesciences Limited
USD 11.21
ZYDUSLIFE.NS
-0.05
-0.42%
Ipsen S.A.
USD 123.52
IPN.PA
-0.02
-0.02%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.02%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.61
600062.SS
+0.01
0.35%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
Zydus Lifesciences Limited
USD 11.21
ZYDUSLIFE.NS
-0.05
-0.42%
Ipsen S.A.
USD 123.52
IPN.PA
-0.02
-0.02%
PT Kalbe Farma Tbk.
USD 0.09
KLBF.JK
-0.00
-1.02%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.61
600062.SS
+0.01
0.35%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%